As the United States continues nuclear modernization on all legs of its nuclear triad through the creation of new variants of warheads, missiles, and delivery platforms, examining the effects of nuclear weapons production on the public is ever more pressing.
The cost of inaction is not merely economic; it is measured in preventable illness, deaths and diminished livelihoods.
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Nearly one year after the Pentagon certified the Sentinel intercontinental ballistic missile program to continue after it incurred critical cost and schedule overruns, the new nuclear missile could once again be in trouble.
As federal uncertainty grows and climate goals face political headwinds, a new coalition of subnational actors is rising to stabilize markets, accelerate permitting, and finance a more inclusive green economy.
Even without weapons present, the addition of a large nuclear air base in northern Europe is a significant new development that would have been inconceivable just a decade-and-a-half ago.
The United States faces urgent challenges related to aging infrastructure, vulnerable energy systems, and economic competitiveness. But the permitting workforce is unprepared to implement changes. Here’s how they can improve.
Improving American competitiveness, security, and prosperity depends on private and public stakeholders’ ability to responsibly site, build, and deploy proposed critical energy, infrastructure, and environmental restoration projects.
The United States is in the midst of a once in a generation effort to rebuild its transportation and mobility systems. Meeting this moment will require bold investments in new and emerging transportation technologies.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.